Search

Your search keyword '"Lo‐Coco, Francesco"' showing total 1,377 results

Search Constraints

Start Over You searched for: Author "Lo‐Coco, Francesco" Remove constraint Author: "Lo‐Coco, Francesco"
1,377 results on '"Lo‐Coco, Francesco"'

Search Results

1. Author Correction: Genome-wide association study identifies susceptibility loci for acute myeloid leukemia

2. Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: a subanalysis from the RATIFY trial

3. Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial

4. Genome-wide association study identifies susceptibility loci for acute myeloid leukemia

6. Validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Summary Score in Patients With Hematologic Malignancies

7. Combining gene mutation with gene expression analysis improves outcome prediction in acute promyelocytic leukemia

8. GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia

9. Transcription factors implicated in late megakaryopoiesis as markers of outcome after azacitidine and allogeneic stem cell transplantation in myelodysplastic syndrome

12. Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet

13. Characteristics and outcome of acute myeloid leukemia with uncommon retinoic acid receptor-alpha (RARA) fusion variants

14. Involvement of central nervous system in adult patients with acute myeloid leukemia: Incidence and impact on outcome

15. Risk-adapted treatment of acute promyelocytic leukemia: results from the International Consortium for Childhood APL

18. Health-related quality of life, symptom burden, and comorbidity in long-term survivors of acute promyelocytic leukemia

19. Vulnerabilities in mIDH2 AML confer sensitivity to APL-like targeted combination therapy

20. Somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes

21. Human Chromosome 7: DNA Sequence and Biology

22. Clinical impact of BAALC expression in high-risk acute promyelocytic leukemia

25. Characterization of FLT3-ITDmut acute myeloid leukemia: molecular profiling of leukemic precursor cells

26. NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia

27. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

31. A rare BCR-ABL1 transcript in Philadelphia-positive acute myeloid leukemia: case report and literature review

32. Supplementary Figure 3 from A Leukemia-Associated CD34/CD123/CD25/CD99+ Immunophenotype Identifies FLT3-Mutated Clones in Acute Myeloid Leukemia

33. Supplementary Table 4 from A Leukemia-Associated CD34/CD123/CD25/CD99+ Immunophenotype Identifies FLT3-Mutated Clones in Acute Myeloid Leukemia

34. Supplementary Table 2 from A Leukemia-Associated CD34/CD123/CD25/CD99+ Immunophenotype Identifies FLT3-Mutated Clones in Acute Myeloid Leukemia

35. Supplementary Figure 2 from A Leukemia-Associated CD34/CD123/CD25/CD99+ Immunophenotype Identifies FLT3-Mutated Clones in Acute Myeloid Leukemia

36. Supplementary Figure 1 from A Leukemia-Associated CD34/CD123/CD25/CD99+ Immunophenotype Identifies FLT3-Mutated Clones in Acute Myeloid Leukemia

37. Supplementary Table 3 from A Leukemia-Associated CD34/CD123/CD25/CD99+ Immunophenotype Identifies FLT3-Mutated Clones in Acute Myeloid Leukemia

38. Supplementary Table 1 from A Leukemia-Associated CD34/CD123/CD25/CD99+ Immunophenotype Identifies FLT3-Mutated Clones in Acute Myeloid Leukemia

39. Supplementary Table 5 from A Leukemia-Associated CD34/CD123/CD25/CD99+ Immunophenotype Identifies FLT3-Mutated Clones in Acute Myeloid Leukemia

40. Data from Sequential Valproic Acid/All-trans Retinoic Acid Treatment Reprograms Differentiation in Refractory and High-Risk Acute Myeloid Leukemia

41. Supplementary Table 1 from Sequential Valproic Acid/All-trans Retinoic Acid Treatment Reprograms Differentiation in Refractory and High-Risk Acute Myeloid Leukemia

44. Hemoglobin levels and circulating blasts are two easily evaluable diagnostic parameters highly predictive of leukemic transformation in primary myelofibrosis

47. Predictors of thrombohemorrhagic early death in children and adolescents with t(15;17)-positive acute promyelocytic leukemia treated with ATRA and chemotherapy

48. The hidden genomic landscape of acute myeloid leukemia: subclonal structure revealed by undetected mutations

Catalog

Books, media, physical & digital resources